JP2010524930A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524930A5
JP2010524930A5 JP2010504040A JP2010504040A JP2010524930A5 JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5 JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5
Authority
JP
Japan
Prior art keywords
pyrido
pyrimidin
dihydro
benzonitrile
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524930A (ja
JP5498374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004208 external-priority patent/WO2008130481A1/en
Publication of JP2010524930A publication Critical patent/JP2010524930A/ja
Publication of JP2010524930A5 publication Critical patent/JP2010524930A5/ja
Application granted granted Critical
Publication of JP5498374B2 publication Critical patent/JP5498374B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504040A 2007-04-17 2008-03-31 ２−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用 Expired - Fee Related JP5498374B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92510907P 2007-04-17 2007-04-17
US60/925,109 2007-04-17
US1051208P 2008-01-08 2008-01-08
US61/010,512 2008-01-08
PCT/US2008/004208 WO2008130481A1 (en) 2007-04-17 2008-03-31 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2010524930A JP2010524930A (ja) 2010-07-22
JP2010524930A5 true JP2010524930A5 (OSRAM) 2011-04-07
JP5498374B2 JP5498374B2 (ja) 2014-05-21

Family

ID=39875785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504040A Expired - Fee Related JP5498374B2 (ja) 2007-04-17 2008-03-31 ２−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用

Country Status (12)

Country Link
US (2) US8076345B2 (OSRAM)
EP (1) EP2139334B1 (OSRAM)
JP (1) JP5498374B2 (OSRAM)
CN (1) CN101677569B (OSRAM)
CA (1) CA2682692A1 (OSRAM)
CY (1) CY1114382T1 (OSRAM)
DK (1) DK2139334T3 (OSRAM)
ES (1) ES2427999T3 (OSRAM)
HR (1) HRP20130867T1 (OSRAM)
PL (1) PL2139334T3 (OSRAM)
PT (1) PT2139334E (OSRAM)
WO (1) WO2008130481A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2262766B1 (en) 2008-02-29 2015-11-11 Evotec AG Amide compounds, compositions and uses thereof
WO2010066629A2 (en) * 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
UA112517C2 (uk) * 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні
AU2014253493B2 (en) * 2010-07-06 2016-04-14 Novartis Ag Tetrahydro-pyrido-pyrimidine derivatives
PH12013502524A1 (en) * 2011-06-27 2014-01-27 Novartis Ag Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
CA2857302C (en) 2011-12-15 2020-08-25 Novartis Ag Use of inhibitors of the activity or function of pi3k
CN103497149A (zh) * 2013-10-08 2014-01-08 南京复兴生物科技有限公司 一种5-氨甲基吡啶衍生物的制备方法
CA2969952A1 (en) 2014-12-09 2016-06-16 Adam James Davenport 1,3-thiazol-2-yl substituted benzamides
US10183937B2 (en) 2014-12-09 2019-01-22 Bayer Aktiengesellschaft 1,3-thiazol-2-yl substituted benzamides
WO2017049498A1 (zh) * 2015-09-23 2017-03-30 前湾医药科技（深圳）有限公司 一种咪唑并吡啶类化合物与在制备pi3k抑制剂中的应用
MX2021010323A (es) * 2019-03-01 2021-12-10 Revolution Medicines Inc Compuestos bicíclicos de heterociclilo y usos de este.
MA56020A (fr) 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés de pyridopyrimidines utilisés en tant qu'inhibiteurs de p2x3
MA56022A (fr) 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
TWI793704B (zh) * 2020-08-06 2023-02-21 大陸商北京泰德製藥股份有限公司 Sos1抑制劑、包含其的藥物組合物及其用途
WO2022112490A1 (en) 2020-11-27 2022-06-02 Chiesi Farmaceutici S.P.A. Amino quinazoline derivatives as p2x3 inhibitors
AU2021386684A1 (en) 2020-11-27 2023-05-25 Chiesi Farmaceutici S.P.A. (aza)quinoline 4-amines derivatives as p2x3 inhibitors
JP2023550831A (ja) 2020-11-27 2023-12-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Ｐ２ｘ３阻害剤としてのフタラジン誘導体
EP4626878A1 (en) 2022-12-02 2025-10-08 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424760A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
DE2502588A1 (de) 1975-01-23 1976-07-29 Troponwerke Dinklage & Co Basisch substituierte derivate des 7-amino-2-chinolons, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP1177188B1 (en) 1999-05-12 2005-10-12 Ortho-McNeil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
US7087589B2 (en) * 2000-01-14 2006-08-08 The United States Of America As Represented By The Department Of Health And Human Services Methanocarba cycloakyl nucleoside analogues
US6531478B2 (en) 2000-02-24 2003-03-11 Cheryl P. Kordik Amino pyrazole derivatives useful for the treatment of obesity and other disorders
EP1301484A2 (en) 2000-07-20 2003-04-16 Neurogen Corporation Capsaicin receptor ligands
ES2241891T3 (es) 2001-01-02 2005-11-01 F. Hoffmann-La Roche Ag Derivados de quinazolona como antagonistas de receptores adrenergicos alfa-1a/b.
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
GB0206033D0 (en) 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
WO2003104230A1 (ja) 2002-06-07 2003-12-18 協和醱酵工業株式会社 二環性ピリミジン誘導体
GB0225908D0 (en) 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
WO2004056774A2 (en) 2002-12-19 2004-07-08 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
TW200530235A (en) * 2003-12-24 2005-09-16 Renovis Inc Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
US7297700B2 (en) * 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2006119504A2 (en) * 2005-05-04 2006-11-09 Renovis, Inc. Fused heterocyclic compounds, and compositions and uses thereof
US8653091B2 (en) * 2007-04-02 2014-02-18 Evotec Ag Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof
US8546388B2 (en) * 2008-10-24 2013-10-01 Purdue Pharma L.P. Heterocyclic TRPV1 receptor ligands

Similar Documents

Publication Publication Date Title
JP2010524930A5 (OSRAM)
JP2010523562A5 (OSRAM)
US20190040025A1 (en) Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application
JP2012502986A5 (OSRAM)
AU2016201584B2 (en) Phosphatidylinositol 3-kinase inhibitors
CN103200822B (zh) 2-取代-8-烷基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-腈和其应用
AU2013234009B2 (en) Heterocyclyl compounds as MEK inhibitors
JP5066175B2 (ja) ヒスタミンｈ４受容体のモジュレーターとしてのベンゾイミダゾール−２−イルピリミジンおよびピラジン
AU2002323475B2 (en) 2-aroylimidazole compounds for treating cancer
JP2011514894A5 (OSRAM)
US8076345B2 (en) 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
JP5204091B2 (ja) 新規なベンジル（ヘテロサイクリックメチル）アミン構造を有するピリミジン化合物及びこれを含有する医薬
EP3475284A1 (en) Pyrrolobenzodiazepines and conjugates thereof
JP2008512348A5 (OSRAM)
WO2017101884A1 (zh) 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
JP2008514643A5 (OSRAM)
WO2018133716A1 (zh) 杂环脲类化合物及其药物组合物和应用
TW201107318A (en) Furazanobenzimidazoles
AU2015335783B2 (en) Tricyclic atropisomer compounds
JP2010520875A5 (OSRAM)
AU2014302550A1 (en) Carbazole carboxamide compounds useful as kinase inhibitors
AU2018338098A1 (en) Cyclic iminopyrimidine derivatives as kinase inhibitors
JP2019510801A5 (OSRAM)
JP2011526911A (ja) ベンゾイミダゾール−２−イルピリミジン誘導体を製造する方法
JP4272056B2 (ja) アリールピペラジンに連結したテトラヒドロインドロン及びプリン誘導体